Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disability accrual in primary and secondary progressive multiple sclerosis.
Harding-Forrester S, Roos I, Nguyen AL, Malpas CB, Diouf I, Moradi N, Sharmin S, Izquierdo G, Eichau S, Patti F, Horakova D, Kubala Havrdova E, Prat A, Girard M, Duquette P, Grand'Maison F, Onofrj M, Lugaresi A, Grammond P, Ozakbas S, Amato MP, Gerlach O, Sola P, Ferraro D, Buzzard K, Skibina O, Lechner-Scott J, Alroughani R, Boz C, Van Pesch V, Cartechini E, Terzi M, Maimone D, Ramo-Tello C, Yamout B, Khoury SJ, La Spitaleri D, Sa MJ, Blanco Y, Granella F, Slee M, Butler E, Sidhom Y, Gouider R, Bergamaschi R, Karabudak R, Ampapa R, Sánchez-Menoyo JL, Prevost J, Castillo-Trivino T, McCombe PA, Macdonell R, Laureys G, Van Hijfte L, Oh J, Altintas A, de Gans K, Turkoglu R, van der Walt A, Butzkueven H, Vucic S, Barnett M, Cristiano E, Hodgkinson S, Iuliano G, Kappos L, Kuhle J, Shaygannejad V, Soysal A, Weinstock-Guttman B, Van Wijmeersch B, Kalincik T; MSBase investigators. Harding-Forrester S, et al. Among authors: turkoglu r. J Neurol Neurosurg Psychiatry. 2023 Sep;94(9):707-717. doi: 10.1136/jnnp-2022-330726. Epub 2023 Apr 17. J Neurol Neurosurg Psychiatry. 2023. PMID: 37068931
Silencing of FCRLB by shRNA ameliorates MuSK-induced EAMG in mice.
Koral G, Ulusoy C, Cossins J, Lazaridis K, Türkoğlu R, Dong YY, Tüzün E, Yılmaz V. Koral G, et al. Among authors: turkoglu r. J Neuroimmunol. 2023 Oct 15;383:578195. doi: 10.1016/j.jneuroim.2023.578195. Epub 2023 Aug 30. J Neuroimmunol. 2023. PMID: 37660538
Reduced serum vitamin D levels in neuromyelitis optica.
Tüzün E, Küçükhüseyin Ö, Kürtüncü M, Türkoğlu R, Yaylım İ. Tüzün E, et al. Among authors: turkoglu r. Neurol Sci. 2015 Sep;36(9):1701-2. doi: 10.1007/s10072-015-2229-7. Epub 2015 Apr 25. Neurol Sci. 2015. PMID: 25911291 No abstract available.
Isolated dysphagia due to aquaporin-4 autoimmunity.
Türkoğlu R, Kiyat-Atamer A, Tüzün E, Akman-Demir G. Türkoğlu R, et al. Turk J Gastroenterol. 2012;23(6):804-5. doi: 10.4318/tjg.2012.0437. Turk J Gastroenterol. 2012. PMID: 23864461 Free article. No abstract available.
A NMOSD case with multifocal nervous system involvement in a single attack.
Tanyel T, Karaaslan Z, Misirli H, Gencer M, Tüzün E, Türkoğlu R. Tanyel T, et al. Among authors: turkoglu r. Mult Scler Relat Disord. 2017 Nov;18:82-84. doi: 10.1016/j.msard.2017.09.019. Epub 2017 Sep 20. Mult Scler Relat Disord. 2017. PMID: 29141827 No abstract available.
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Confavreux C, O'Connor P, Comi G, Freedman MS, Miller AE, Olsson TP, Wolinsky JS, Bagulho T, Delhay JL, Dukovic D, Truffinet P, Kappos L; TOWER Trial Group. Confavreux C, et al. Lancet Neurol. 2014 Mar;13(3):247-56. doi: 10.1016/S1474-4422(13)70308-9. Epub 2014 Jan 23. Lancet Neurol. 2014. PMID: 24461574 Clinical Trial.
94 results